Affymetrix Q1 Revenues Rise 7 Percent on Increased Product Sales | GenomeWeb

NEW YORK (GenomeWeb) – Affymetrix reported after the close of the market today first quarter revenue growth of 7 percent, an increase the company attributed to the strong performance of its genotyping and reproductive health business.

For the three months ended March 31, the company's revenues increased to $88.7 million from $83 million in the year-ago quarter. On a constant currency basis, its revenues increased 9 percent year over year, and beat the average Wall Street estimate of $86.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.